The role of connexin proteins (Cx), which form gap junctions (GJ), in progression and
chemotherapeutic sensitivity of cervical cancer (CaCx), is unclear. Using cervix
specimens (313 CaCx, 78 controls) and CaCx cell lines, we explored relationships
among Cx expression, prognostic variables and mechanisms that may link them. In CaCx
specimens, Cx32 was upregulated and cytoplasmically localized, and three other Cx
downregulated, relative to controls. Cx32 expression correlated with advanced FIGO
staging, differentiation and increased tumor size. In CaCx cell lines, Cx32
expression suppressed streptonigrin/cisplatin-induced apoptosis in the absence of
functional GJ. In CaCx specimens and cell lines, expression of Cx32 upregulated
epidermal growth factor receptor (EGFR) expression. Inhibition of EGFR signaling
abrogated the anti-apoptotic effect of Cx32 expression. In conclusion, upregulated
Cx32 in CaCx cells produces anti-apoptotic, pro-tumorigenic effects in vivo
and vitro. Abnormal Cx32 expression/localization in CaCx appears to be
both a mechanism and biomarker of chemotherapeutic resistance.